Tufts Center for the Study of Drug Development

Tufts Center for the Study of Drug Development
Formation 1976 (1976)
Founder Louis Lasagna
Type Think tank
Purpose Researching drug development
Location
Director
Kenneth I. Kaitin
Website csdd.tufts.edu

The Tufts Center for the Study of Drug Development is a nonprofit think tank at Tufts University in Boston, dedicated to researching drug development. It was established in 1976 by American physician Louis Lasagna.[1] The Center receives 40% of its funding from the pharmaceutical industry.[2]

Research

The Center has issued numerous studies estimating the cost of developing a new drug: In 2001, researchers from the Center estimated that the cost of doing so was $802 million,[3] and in 2014, they released a study estimating that this amount had risen to nearly $2.6 billion.[2] This study was criticized by Medecins Sans Frontieres, which said it was unreliable because the industry's research and development spending is not made public.[4] Aaron Carroll of the New York Times also criticized the study, saying it "contains a lot of assumptions that tend to favor the pharmaceutical industry."[5]

References

  1. History
  2. 1 2 Silverman, Ed (20 November 2014). "What Does It Cost to Develop a New Drug? Latest Study Says $2.6 Billion". Wall Street Journal. Retrieved 21 November 2014.
  3. Pear, Robert (1 December 2001). "Research Cost For New Drugs Said to Soar". New York Times. Retrieved 21 November 2014.
  4. Pierson, Ransdell (18 November 2014). "CORRECTED-Tufts says average new drug costs $2.6 bln to develop, critics wary". Reuters. Retrieved 21 November 2014.
  5. Carroll, Aaron (19 November 2014). "$2.6 Billion to Develop a Drug? New Estimate Makes Questionable Assumptions". New York Times. Retrieved 25 November 2014.
This article is issued from Wikipedia - version of the Thursday, April 14, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.